Screening for CAD in asymptomatic patients with type 2 diabetes did not reduce risk of cardiac events
Study design
Design:
randomised controlled trial (Detection of Ischemia in Asymptomatic Diabetics [DIAD]). ClinicalTrials.gov NCT00769275.
Allocation:
concealed.*
Blinding:
blinded (outcome adjudication committee).*
Study question
Setting:
14 centres in the USA and Canada.
Patients:
1123 patients 50–75 years of age (mean age 61 y, 54% men) who had type 2 diabetes diagnosed at ≥30 years of age, no symptomatic or previously recognised coronary artery disease (CAD), and no history of ketoacidosis.
Intervention:
screening with adenosine-stress radionuclide myocardial perfusion imaging …








